Heterocyclic compounds as pharmaceutical agents

Details for Australian Patent Application No. 2005272916 (hide)

Owner Exelixis, Inc.

Inventors Martin, Richard; Kahl, Jeffrey Dean; Flatt, Brenton Todd

Agent Davies Collison Cave

Pub. Number AU-A-2005272916

PCT Pub. Number WO2006/020680

Priority 60/600,239 10.08.04 US

Filing date 9 August 2005

Wipo publication date 23 February 2006

International Classifications

A61K 31/426 (2006.01) - 1,3-Thiazoles

C07D 277/04 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/020680 Priority application(s): WO2006/020680

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005272919-Methods for treating premature infants

2005272912-Antisense modulation of apolipoprotein B expression